Norwood, MA, United States of America

Adulla P Reddy


Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Norwood, MA (US) (2001 - 2008)
  • Walpole, MA (US) (2008 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adulla P Reddy

Introduction

Adulla P Reddy is a notable inventor based in Norwood, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Reddy has made strides in developing compounds that address various medical conditions.

Latest Patents

Among his latest patents, Reddy has developed pyrazolidinone compounds that serve as ligands for the prostaglandin EP2 and/or EP4 receptors. This invention provides substituted pyrazolidinone compounds, along with methods of treatment and pharmaceutical compositions that utilize these compounds. The applications of these compounds are extensive, including therapies for preterm labor, dysmenorrhea, asthma, hypertension, infertility, undesired blood clotting, and other disorders associated with the prostaglandin receptors. Additionally, he has patented substituted pyrazole compounds that are useful for treating mammalian infertility.

Career Highlights

Reddy has worked with several prominent companies throughout his career, including Applied Research Systems and Laboratoires Serono. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Reddy has collaborated with notable professionals in his field, including Nabil El Tayer and David Rogers Buckler. These collaborations have further enhanced his innovative efforts and contributions to the industry.

Conclusion

Adulla P Reddy's work exemplifies the impact of innovation in pharmaceuticals, particularly through his patented compounds that address critical health issues. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…